Mark S. Gresnigt

8.0k citations

80 papers · 4.5k · 2 hit papers · h-index 35

Impact in

Infectious Diseases top 0.5%
- Antifungal resistance and susceptibility
Immunology top 2%
- Immune Response and Inflammation
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune cells in cancer

Papers in

Infectious Diseases 53
- Antifungal resistance and susceptibility 52
Epidemiology 34
- Fungal Infections and Studies 26

Co-authors: Frank L. van de Veerdonk (42 shared papers)Mihai G. Netea (36 shared papers)Leo A. B. Joosten (24 shared papers)Bernhard Hube (21 shared papers)Jean‐Paul Latgé (8 shared papers)Luigina Romani (3 shared papers)J.W.M. van der Meer (6 shared papers)Rob J.W. Arts (5 shared papers)
Journals: PLoS Pathogens (5 papers)Nature Communications (4 papers)European Journal of Immunology (3 papers)mBio (3 papers)The Journal of Infectious Diseases (3 papers)
Partner nations: Netherlands Germany United States

In The Last Decade

Mark S. Gresnigt

79 papers receiving 4.4k citations

Mark S. Gresnigt's Hit Papers

align trajectories log scale

Aspergillus fumigatus morphology and dynamic host interactions 2017 · 354 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 Nature Reviews Microbiology
2016 Nature Immunology

Peers

Countries citing papers authored by Mark S. Gresnigt

Since Specialization

Citations

This map shows the geographic impact of Mark S. Gresnigt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Gresnigt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Gresnigt more than expected).

Fields of papers citing papers by Mark S. Gresnigt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Gresnigt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Gresnigt. The network helps show where Mark S. Gresnigt may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark S. Gresnigt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark S. Gresnigt Line = papers co-authored together Mark S. Gresnigt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis Nature Immunology ·Shih‐Chin Cheng, Brendon P. Scicluna, Rob J.W. Arts, Mark S. Gresnigt, Ekta Lachmandas, Evangelos J. Giamarellos‐Bourboulis, Matthijs Kox, Ganesh R. Manjeri, Jori A. Wagenaars, Olaf L. Cremer, Jenneke Leentjens, Anne Jan van der Meer, Frank L. van de Veerdonk, Marc J. M. Bonten, Marcus J. Schultz, Peter H.G.M. Willems, Peter Pickkers, Leo A. B. Joosten, Tom van der Poll, Mihai G. Netea Hit paper breakdown →	2016	462
2	Aspergillus fumigatus morphology and dynamic host interactions Nature Reviews Microbiology ·Frank L. van de Veerdonk, Mark S. Gresnigt, Luigina Romani, Mihai G. Netea, Jean‐Paul Latgé Hit paper breakdown →	2017	354
3	IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans Proceedings of the National Academy of Sciences ·Antonella De Luca, Sanne P. Smeekens, Andrea Casagrande, Rossana G. Iannitti, Kara L. Conway, Mark S. Gresnigt, Jakob Begun, Theo S. Plantinga, Leo A. B. Joosten, J.W.M. van der Meer, Georgios Chamilos, Mihai G. Netea, Ramnik J. Xavier, Charles A. Dinarello, Luigina Romani, Frank L. van de Veerdonk	2014	240
4	The fungal peptide toxin Candidalysin activates the NLRP3 inflammasome and causes cytolysis in mononuclear phagocytes Nature Communications ·Lydia Kasper, Annika König, Paul-Albert Koenig, Mark S. Gresnigt, Johannes Westman, Rebecca A. Drummond, Michail S. Lionakis, Olaf Groß, Jürgen Ruland, Julian R. Naglik, Bernhard Hube	2018	215
5	Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series BMC Infectious Diseases ·Corine Delsing, Mark S. Gresnigt, Jenneke Leentjens, Frank Preijers, Florence Allantaz Frager, Matthijs Kox, Guillaume Monneret, Fabienne Venet, Chantal P. Bleeker‐Rovers, Frank L. van de Veerdonk, Peter Pickkers, Alexandre Pachot, Bart Jan Kullberg, Mihai G. Netea	2014	191
6	Integrated transcriptomic and proteomic analyses ofP. falciparumgametocytes: molecular insight into sex-specific processes and translational repression Nucleic Acids Research ·Edwin Lasonder, Sanna R. Rijpma, Ben C. L. van Schaijk, Wieteke A. M. Hoeijmakers, Philip Kensche, Mark S. Gresnigt, Annet Italiaander, Martijn Vos, Rob Woestenenk, Teun Bousema, Gunnar R. Mair, Shahid M. Khan, Chris J. Janse, Richárd Bártfai, Robert W. Sauerwein	2016	184
7	Aspergillus Cell Wall Melanin Blocks LC3-Associated Phagocytosis to Promote Pathogenicity Cell Host & Microbe ·Tonia Akoumianaki, Irene Kyrmizi, Isabel Valsecchi, Mark S. Gresnigt, George Samonis, Ηλίας Δράκος, Dimitrios T. Boumpas, Laetitia Muszkieta, Marie-Christine Prévost, Dimitrios P. Kontoyiannis, Triantafyllos Chavakis, Mihai G. Netea, Frank L. van de Veerdonk, Axel A. Brakhage, Jamel El‐Benna, Anne Beauvais, Jean‐Paul Latgé, Georgios Chamilos	2015	172
8	A three-dimensional immunocompetent intestine-on-chip model as in vitro platform for functional and microbial interaction studies Biomaterials ·Michelle Maurer, Mark S. Gresnigt, Antonia Last, Tony Wollny, Florian Berlinghof, Rebecca Pospich, Zoltán Cseresnyés, Anna Medyukhina, Katja Graf, Marko Gröger, Martin Raasch, Fatina Siwczak, Sándor Nietzsche, Ilse D. Jacobsen, Marc Thilo Figge, Bernhard Hube, Otmar Huber, Alexander S. Mosig	2019	153
9	Biology of IL-36 cytokines and their role in disease Seminars in Immunology ·Mark S. Gresnigt, Frank L. van de Veerdonk	2013	147
10	The gut, the bad and the harmless: Candida albicans as a commensal and opportunistic pathogen in the intestine Current Opinion in Microbiology ·Carol A. Kumamoto, Mark S. Gresnigt, Bernhard Hube	2020	147
11	A Polysaccharide Virulence Factor from Aspergillus fumigatus Elicits Anti-inflammatory Effects through Induction of Interleukin-1 Receptor Antagonist PLoS Pathogens ·Mark S. Gresnigt, Silvia Bozza, Katharina L. Becker, Leo A. B. Joosten, Shahla Abdollahi‐Roodsaz, Wim B. van der Berg, Charles A. Dinarello, Mihai G. Netea, Thierry Fontaine, Antonella De Luca, Silvia Moretti, Luigina Romani, Jean‐Paul Latgé, Frank L. van de Veerdonk	2014	118
12	Corticosteroids Block Autophagy Protein Recruitment in Aspergillus fumigatus Phagosomes via Targeting Dectin-1/Syk Kinase Signaling The Journal of Immunology ·Irene Kyrmizi, Mark S. Gresnigt, Tonia Akoumianaki, George Samonis, Prodromos Sidiropoulos, Dimitrios T. Boumpas, Mihai G. Netea, Frank L. van de Veerdonk, Dimitrios P. Kontoyiannis, Georgios Chamilos	2013	113
13	Rewiring cellular metabolism via the AKT/mTOR pathway contributes to host defence against Mycobacterium tuberculosis in human and murine cells European Journal of Immunology ·Ekta Lachmandas, Macarena Beigier‐Bompadre, Shih‐Chin Cheng, Vinod Kumar, Arjan van Laarhoven, Xinhui Wang, Anne Ammerdorffer, Lily Boutens, Dirk de Jong, Thirumala‐Devi Kanneganti, Mark S. Gresnigt, Tom H. M. Ottenhoff, Leo A. B. Joosten, Rinke Stienstra, Cisca Wijmenga, Stefan H. E. Kaufmann, Reinout van Crevel, Mihai G. Netea	2016	111
14	Immunotherapeutic approaches to treatment of fungal diseases The Lancet Infectious Diseases ·Darius Armstrong‐James, Gordon D. Brown, Mihai G. Netea, Teresa Zelante, Mark S. Gresnigt, Frank L. van de Veerdonk, Stuart M. Levitz	2017	99
15	The IL‐36 receptor pathway regulates Aspergillus fumigatus‐induced Th1 and Th17 responses European Journal of Immunology ·Mark S. Gresnigt, Berenice Rösler, Cor Jacobs, Katharina L. Becker, Leo A. B. Joosten, J.W.M. van der Meer, Mihai G. Netea, Charles A. Dinarello, Frank L. van de Veerdonk	2012	93
16	Th17 responses and host defense against microorganisms: an overview BMB Reports ·Frank L. van de Veerdonk, Mark S. Gresnigt, Bart Jan Kullberg, J.W.M. van der Meer, Leo A. B. Joosten, Mihai G. Netea	2009	91
17	Cellular metabolism of myeloid cells in sepsis Journal of Leukocyte Biology ·Rob J.W. Arts, Mark S. Gresnigt, Leo A. B. Joosten, Mihai G. Netea	2016	88
18	Rewiring monocyte glucose metabolism via C-type lectin signaling protects against disseminated candidiasis PLoS Pathogens ·Jorge Domínguez‐Andrés, Rob J.W. Arts, Rob ter Horst, Mark S. Gresnigt, Sanne P. Smeekens, Jacqueline M. Ratter, Ekta Lachmandas, Lily Boutens, Frank L. van de Veerdonk, Leo A. B. Joosten, Richard A. Notebaart, Carlos Ardavı́n, Mihai G. Netea	2017	72
19	Lactobacillus rhamnosus colonisation antagonizes Candida albicans by forcing metabolic adaptations that compromise pathogenicity Nature Communications ·Raquel Alonso‐Román, Antonia Last, Mohammad H. Mirhakkak, Jakob L. Sprague, Lars Møller, Peter Großmann, Katja Graf, Rena Gratz, Selene Mogavero, Slavena Vylkova, Gianni Panagiotou, Sascha Schäuble, Bernhard Hube, Mark S. Gresnigt	2022	67
20	Pattern recognition pathways leading to a Th2 cytokine bias in allergic bronchopulmonary aspergillosis patients Clinical & Experimental Allergy ·Katharina L. Becker, Mark S. Gresnigt, Sanne P. Smeekens, C. W. Jacobs, Cecile Magis‐Escurra, Martin Jaeger, X. Wang, Rosalie Lubbers, Marije Oosting, Leo A. B. Joosten, Mihai G. Netea, Monique H. Reijers, Frank L. van de Veerdonk	2014	66

About Mark S. Gresnigt

Mark S. Gresnigt is a scholar working on Infectious Diseases, Epidemiology, Immunology, Molecular Biology and Microbiology, having authored 80 papers that have together received 4.5k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (52 papers), Fungal Infections and Studies (26 papers), Gut microbiota and health (11 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (8 papers), Infectious Diseases and Mycology (7 papers), Reproductive tract infections research (7 papers), Immune Response and Inflammation (6 papers) and Immune cells in cancer (4 papers). The work is most often cited by research in Infectious Diseases (1.8k citations), Immunology (1.4k citations), Epidemiology (1.5k citations), Microbiology (205 citations) and Small Animals (198 citations). Mark S. Gresnigt has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Frank L. van de Veerdonk, Mihai G. Netea, Leo A. B. Joosten, Bernhard Hube, Jean‐Paul Latgé, Luigina Romani, J.W.M. van der Meer, Rob J.W. Arts, Charles A. Dinarello and Carol A. Kumamoto. Their work appears in journals such as PLoS Pathogens, Nature Communications, European Journal of Immunology, mBio and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Mark S. Gresnigt

Impact in

Papers in i

In The Last Decade

Mark S. Gresnigt

Mark S. Gresnigt's Hit Papers

Peers

Countries citing papers authored by Mark S. Gresnigt

Fields of papers citing papers by Mark S. Gresnigt

All Works

About Mark S. Gresnigt

Explore authors with similar magnitude of impact

Papers in